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Osteoarthritis (OA) is one of the most prevalent musculoskeletal joint conditions throughout the world. In 2 
the UK alone, it is estimated that more than 4.7 million people over the age of 45 years have sought 3 
treatment from their general practitioner for knee osteoarthritis (1). As a weight-bearing joint the knee is 4 
highly susceptible to OA, with the medial compartment of the knee joint more commonly affected. An 5 
increased incidence of medial compartment knee OA (mKOA) has been attributed to the combination of 6 
greater varus alignment (2) and the higher percentage of overall joint load being transmitted across the 7 
medial compartment compared to the lateral compartment (approximately 70:30) (3). 8 
Direct measurement of knee joint load is complex, with most in vivo contact loading studies restricted to 9 
case studies, conducted using instrumented prostheses following knee replacement surgery (4–8). For 10 
non-invasive studies, the knee adduction moment (KAM) is routinely adopted as a surrogate measure 11 
whereby it is used to infer the dynamic load placed on the compartments of the knee (3,9,10). This 12 
external moment is mainly determined by the ground reaction force vector and its lever arm to the centre 13 
of the knee joint. Using this measure, increased KAMs reflect greater medial compartment loading. 14 
Foot orthoses (FOs) incorporating lateral wedges are routinely issued for individuals with mKOA. These 15 
are intended to assist in the control and management of the disease by redistributing the total knee joint 16 
load across the joint during weight bearing tasks, alleviating load on the affected medial compartment. 17 
They function by causing an increased valgus moment at the ankle which causes a lateral shift of the 18 
centre of pressure at the foot. This lateral shift causes the lever arm length of the ground reaction force 19 
vector relative to the knee joint origin to reduce, resulting in the theoretical reduction in the KAM.   20 
The use of lateral wedged FOs has been shown to reduce the peak KAM by approximately 4-12 % in 21 
KOA cohorts (11,12). However, there is growing evidence that the biomechanical response to orthotic 22 
intervention is heterogeneous and can, in some individuals, in fact elevate the KAM. Indeed it has been 23 
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estimated that 13–33% of people with mKOA demonstrate a negative response to lateral wedged insoles, 24 
despite beneficial effects reported at group level (12–16).  25 
The majority of RCTs that have applied FO interventions for mKOA have generally focused on the 26 
application of a single intervention device and compared it to a control condition, which varied between 27 
studies(14,15,17,18). It should however be considered that the requirements for a beneficial 28 
biomechanical response are likely to be more complex than a straightforward one-size-fits-all 29 
intervention. It may be that different design characteristics will be effective in some individuals and not 30 
others, especially when the heterogeneity of the OA population is taken into consideration.  31 
Advances in 3D printing technologies have resulted in the expansion of these techniques into the orthotic 32 
environment (19–22) with numerous companies currently offering 3D printed FOs including Peacocks 33 
Medical Group©  and SOLS Systems©.  Studies which have adopted the combination of 3D surface 34 
scanning, computer-aided design and computer-aided manufacturing (CAD/CAM) have produced custom 35 
FOs of equivalent quality to traditional methods with improved reproducibility and design standardisation 36 
(23). The application of these methods serves as a useful alternative to standard methods as it allows the 37 
creation of multiple personalised FOs facilitating small scale orthotic production for research. The ability 38 
to optimise orthotic design is specifically relevant in the mKOA population given the high variability 39 
between responses previously reported. The aim of this study therefore was to evaluate the immediate 40 
biomechanical effect, at both group level and individual level when two key design features are altered in 41 
personalised FOs: orthotic length and degree of lateral wedging.  42 
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Materials and methods 43 
Study design 44 
This cross-sectional observational study was conducted in a human performance laboratory at Glasgow 45 
Caledonian University from November of 2013 to February 2015. Participants completed all orthotic 46 
conditions on the same day.  47 
Participants 48 
Approval was obtained from the Institutional Research Ethics Committee at Glasgow Caledonian 49 
University. The procedures followed were in accordance with the ethical standards of the aforementioned 50 
research committee and with the Helsinki Declaration of 1975, revised in 2000. 20 participants were 51 
enrolled in the study, 10 in the mKOA group and 10 in the control group. All participants provided 52 
informed, written consent upon enrolment.  53 
A convenient sample of mKOA participants was recruited via email to staff members of departments 54 
within the university and their associated friends and family as well as a MSK rehabilitation research 55 
email address which targets the community. Inclusion criteria for the mKOA group were ≥50 years of age 56 
and physician-confirmed unilateral or bilateral mKOA. Inclusion criteria for the control group were: ≥50 57 
years; no history of unilateral/bilateral KOA; and have no chronic/stable knee pain in the past 3 months. 58 
Exclusion criteria for both groups were: BMI ≥ 36 kg/m2; history of lower limb, hip or spinal surgery 59 
within the past 6 months; any other joint pathology which causes knee pain; received corticosteroid or 60 
other injections to or around the knee in the past 6 months; current or past (within 4 week) use of oral 61 
corticosteroids; any medical condition that may affect walking; current use of wedge insole/custom-made 62 
orthotics; and an aggregate foot posture index score (FPI) < -9 or 9 > (24).  This was assessed by a UK 63 
Health and Care Professions Council registered podiatrist (MA). 64 
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FO design and manufacturing 65 
To design the FOs first weight-bearing 3D surface scans of both feet were taken with the foot in a relaxed 66 
standing position using an Easy-Foot-Scan 3D scanner (Baltic Orthoservice UAB, Kaunas, Lithuania. The 67 
application of 3D scanners to measure characteristics of foot shape  have previously demonstrated 68 
reduced measurement variability compared to a traditional neutral suspension casting technique, 69 
irrespective of clinical experience (25) . The generated 3-D model was converted into stl format and then 70 
exported into OrthoModel Pro 2013 computer aided design (CAD) Software (Delcam Plc, Birmingham, 71 
UK) to undergo the FO design steps. One CAD user with low level prior experience to CAD software and 72 
of biomechanical background (RA) was responsible for all stages of the design and manufacturing 73 
process. The user however had received formal training in its use prior to study commencement from a 74 
CAD expert (ST), who was in regular user of the OrthoModel software, designing 2 or 3 pairs of FOs per 75 
week over the previous 2/3 years.  76 
In the software, all FOs were designed using the “standard orthosis from scan” mode. This mode used the 77 
identification of specific anthropometric measurements of the foot model obtained from the foot scans to 78 
design the FO. These measurements included; forefoot width (mm), rearfoot width (mm), orthotic length 79 
(mm) and medial arch height (mm). Forefoot width was determined by the locations of the centre of the 80 
1st and 5th metatarsal heads, rearfoot width based on the medial and lateral aspect of the heel at its widest 81 
point and the medial longitudinal arch height was determined by selecting the most proximal point of the 82 
arch relative to the plantar surface.  83 
The implementation of these dimensions provided the basis for the model which could then be altered as 84 
such based on key design characteristics of degree of wedging and FO length. In the software, degree of 85 
wedging was set at extrinsic, lateral (valgus) resulting in alterations to the wedging of the surface in 86 
contact with the foot. Position of wedging could be applied to the rearfoot, forefoot or a combination of 87 
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both to give the required design. FO length was adjusted in the software with finer adjustments being 88 
made based on individual foot shape. All FOs had a set default thickness of 3.5mm with a solid heel 89 
component section. This was selected in accordance with routinely applied and generally accepted insole 90 
thickness measurements.  91 
In total eight variations to the neutral design FO were produced and manufactured for the most 92 
symptomatic side in the mKOA group, as measured by a VAS scale for pain; or randomly chosen for the 93 
healthy group. Variations under investigation included both a ¾ length and a full length FO with the 94 
following degrees of wedging; 0° ‘neutral’, 5° rearfoot lateral wedging, 10° rearfoot lateral wedging and 95 
combination of 5° forefoot and 10° rearfoot lateral wedging. The non-test leg received a 0° ‘neutral’ 96 
posted FO of equivalent length during each test condition to remove any chance of altered gait patterns 97 
from differences in FO length. The FO design process took approximately 1.5-2 hours for all eight 98 
variations per participant. The fabrication time for the eight variations (10 insoles per participant; one set 99 
of neutral full length, one set of three-quarter full length and the six variations of the assigned test leg) 100 
was approximately 70-120 hours, depending on participants shoe size. 101 
Fused Deposition Modelling (FDM) 102 
All FOs were manufactured via a Fused Deposition Modelling (FDM) approach using a desktop 3D 103 
printing system (3d Touch; Bits from Bytes, Clevedon, UK).  FDM is a method of additive manufacturing 104 
(AM) first patented and trademarked by Stratasys Inc. which involves building a 3D object layer-by-105 
layer. Also commonly referred to as plastic jet printing (PJP) and fused filament fabrication (FFF), 106 
recently the method has become open sourced resulting in a more consumer driven application and 107 
increased number of marketed products.   108 
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The 3D printing system used was a commercially available 3D printer and although its application is not 109 
specific to FO manufacturing, it had previously been used in similar published studies by the research 110 
group, allowing manufacturing to be performed in-house (23,26).  FOs were manufactured in a soft 111 
polylactide (PLA) thermoplastic (www.orbi-tech.de: density- > 1.35 g/cm3, tensile strength- ~ 16 MPa, 112 
strain at yield- ~ 290%, e-modulus- ~ 380 MPa, shore hardness- 92A). This semi-rigid thermoplastic 113 
polymer was selected as the material of choice based on previously published studies by the research 114 
group (23,26).  115 
Axon 2 software (Bits from Bytes, Clevedon, UK) was used to prepare the FOs for printing. The software 116 
functions by mathematically slicing the FO into layers and creating the toolpaths for each layer which the 117 
3D printer follows. Build settings used to print the FOs involved; a layer height of 0.25mm, fill density of 118 
52% and a printing temperature of 195°C with the inclusion of a printed raft and support material.   119 
The FDM process of the 3D printing system functions by feeding the thermoplastic material at a set feed 120 
rate (16mm/s) through a temperature controlled nozzle head. Once in contact with the heating element 121 
inside the nozzle, the solid thermoplastic filament is heated towards its melting temperature, altering its 122 
structure into a molten, semi-liquid state. The nozzle travels in the X and Y directions and extrudes the 123 
molten thermoplastic material at a set flow rate (20 RPM) according to the toolpath for the layer, creating 124 
a cross sectional 2D layer on the build platform. Once complete, the build platform is lowered by a set 125 
height (0.25mm) and the next layer is printed based on the next cross sectional layer. During this process, 126 
the two layers are bonded together through thermal fusion and then solidify together as the layers cool 127 
down. This process is repeated for each of the toolpath layers until the FO is complete. Once printed, 128 
support structures and rafts were manually removed and each FO was hand finished using sandpaper to 129 
ensure a sufficient surface quality suitable for wear during biomechanical evaluation.  130 




Participants were tested in their own footwear to replicate their normal daily wear and comfort levels. A 133 
four segment unilateral model was created for the test leg using a modified version of the Cleveland 134 
Clinic marker set. This included markers placed bilaterally on the anterior and posterior superior iliac 135 
spine and greater trochanters. Additionally, for the test leg, markers were placed on the lateral femoral 136 
condyle, lateral malleolus, and on the shoe itself, over the posterior calcaneus, 1
st
 metatarsal head and the 137 
5
th
 metatarsal head. To track the thigh and shank segments, shell-mounted clusters of four tracking 138 
markers were placed on the lateral aspects of these segments.  During the initial static standing trial 139 
additional markers were placed on the medial femoral condyle and medial malleolus to determine relative 140 
positioning of joint centres and were removed for dynamic trials.  141 
For trials, a 14 camera motion capture system (Qualisys AB, Gothenburg, Sweden) operating at a 142 
frequency of 120 Hz was used to capture the retroreflective markers. Simultaneously, a force plate 143 
(9286B; Kistler Winterthur, Switzerland) embedded into the walkway was used to measure the ground 144 
reaction forces at 2400 Hz. These data capturing methods are standard practice in research investigating 145 
the biomechanics of human movement.  146 
After an initial FO fitting session and accommodation period of approximately one week, participants 147 
returned to the laboratory for the main evaluation. A static trial was recorded with the participant standing 148 
in the shod condition, and then anatomical markers were removed prior to collection of dynamic trials. 149 
Walking trials were measured for the shod condition followed by eight FO conditions. Testing order was 150 
randomised for each participant to avoid order effects and participants were blinded to the condition 151 
during testing. 152 
Participants were given time to acclimatise to each FO until a consistent gait pattern was observed. They 153 
were then asked to walk along the walkway until a total of 7 successful force plate strikes with the test leg 154 
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were recorded. Walking speed was standardised to within ±10% of their self-selected walking speed 155 
during the shod test using photoelectric timing gates (Brower timing system, Draper, Utah, USA). A rest 156 
period was included between FO conditions to reduce potential effects of fatigue. 157 
Knee joint moments were calculated from inverse dynamic analysis using Visual 3-D software (C-motion 158 
Inc., Germantown, MD). Variables associated with knee joint loading were identified and analysis was 159 
limited to these. These included;  peak knee adduction moment during the 1
st
 half of stance phase 160 
(1KAM); peak knee adduction moment during the 2
nd
 half of stance phase (2KAM); knee flexion moment 161 
during the 1
st
 half of stance phase (1KFM); and the knee adduction moment impulse (KAMI) i.e. integral 162 
of the total KAM. Kinetic variables were anatomically referenced to the proximal segment. All variables 163 
of interest were normalised by dividing by body weight multiplied by height and then expressed as a 164 
percentage (For 1KAM, 2KAM and 1KFM this was Nm/ % body weight x height; for KAMI this was 165 
Nms
-1
/ % body weight x height. This normalisation approach allowed for the effects of height and 166 
bodyweight to be considered-factors which significantly influence joint kinetics (27). The mean of the 167 
final 5 successful walking trials from each test condition with complete marker tracking was used in the 168 
analysis. Marker trajectories and GRF data were low passed filtered with a 4
th
 order Butterworth filter at 6 169 
Hz and 25 Hz, respectively.  170 
Statistical Analysis 171 
Statistical analyses were performed with SPSS (Norusis/SPSS, Chicago, IL) using α level of 0.05. Data 172 
were checked for normality, through Shapiro-Wilks tests, prior to analysis. All kinetic variables used in 173 
the analysis indicated normally distributed results. For analysis, all variables were defined relative to the 174 
shod condition, considered the baseline for the study and evaluated using a 3-factor, repeated-measures 175 
ANOVA to determine the main effect for group, length, wedging type and any interaction effects. 176 




Demographic characteristics of study cohorts are presented in table 1. The mKOA group was significantly 179 
older and had a higher BMI than the healthy control group.  180 
INSERT TABLE 1 181 
Mean 1KAM, 2KAM, 1KFM and KAM Impulse values for each condition and group are presented in 182 
table 2. 183 
INSERT TABLE 2  184 
ANOVA results on all test variables are presented in table 3. Variable definitions include main effects of: 185 
orthotic length (three-quarter length/full length); group, (mKOA/control group); and wedging (0° 186 
‘neutral’, 5° rearfoot wedging; 10° rearfoot wedging and a combination of 5° forefoot 10° rearfoot 187 
wedging). Interaction effects between these variables are also provided.   188 
INSERT TABLE 3 189 
1KAM 190 
Significant main effects were found for orthotic length in 1KAM (p= 0.038). At the group level both FO 191 
lengths provided mean overall reductions in 1KAM compared to shod. This corresponded to a mean ± SD 192 
percentage reduction in peak knee adduction moment in the 1st half of stance of 1.1% ± 12.3 for the 193 
three-quarter length FOs and 2.8% ± 12.4 for the full lengths FOs.  194 
Wedging condition was also found to be statistically significant for 1KAM (p<0.001). With the exception 195 
of the neutrally posted FOs (2% ± 11.3 increase) 1KAM was reduced for all wedging conditions. This 196 
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corresponded to a mean ± SD percentage reduction in 1KAM of  2.3% ± 9.2, 4% ± 8.3 and 3.5% ± 8.7 for 197 
the  5° rearfoot; 10° rearfoot and combined 5° forefoot/ 10° rearfoot wedging conditions respectively.   198 
No significant interaction effects were found between the length of orthotic or level of wedging. 199 
Furthermore no significant difference existed between the mKOA and healthy group 200 
2KAM 201 
Significant main effects were found for orthotic length in 2KAM (p= 0.018).  At the group level both FO 202 
lengths provided a mean overall increase in 2KAM compared to the shod condition. This increase 203 
corresponded to a mean ± SD percentage increase in 2KAM of 6.5 % ± 16.9 for the three-quarter length 204 
FOs and 4.1% ± 19.1 for full length FOs. 205 
An interaction effect was also found between FO length and group (p= 0.028). For the mKOA group 206 
these differences corresponded to mean ± SD percentage changes of 2.9% ± 16.9 and 2.7% ± 19.1 for the 207 
three-quarter length and full length FOs respectively. The healthy group showed greater increases in 208 
2KAM corresponding to mean ± SD percentage changes of  10.2% ± 16.9 and 5.5% ± 19.1 for the three-209 
quarter length and full length FOs respectively. 210 
Significant main effects were found for wedging for 2KAM (p< 0.0001). Irrespective of the orthotic 211 
length, FOs had a somewhat negative effect on 2KAM,  corresponding to mean ± SD percentage 212 
increases in peak 2KAM of  9.5% ± 12.9, 5.8% ± 12.5 and 6.1% ± 15.6 for the neutral, 5° rearfoot; 10° 213 
rearfoot wedging conditions respectively. No significant differences were found between OA and the 214 
healthy groups. Furthermore, significant differences existed between the combined 5° forefoot and 10° 215 
rearfoot FO, considered the most biomechanically aggressive FO and all other wedging conditions. For 216 
this condition when compared to other wedging conditions there was a reduction of 9.6%, 5.9% and 6.6% 217 
11 
 
when compared to the neutral, 5° rearfoot; 10° rearfoot wedging conditions respectively. However 218 
compared to the shod condition it only produced a minimal 2KAM reduction of 0.1% (13.4).  219 
Other significant interaction effects were found between orthotic length and wedging condition for 220 
2KAM (p=0.002). For the three-quarter length FOs alterations to wedging corresponded to mean ± SD 221 
percentage changes of 9.1% ± 10.1,  6.6 % ± 9.5, 5.9% ± 10.6 and 4.5 % ± 9.6 for the neutral, 5° rearfoot, 222 
10° rearfoot and combined 5° forefoot/ 10° rearfoot wedging conditions respectively. Full length FOs 223 
demonstrated a similar dose response with the exception of combined 5° forefoot/ 10° rearfoot wedging 224 
condition, corresponding to mean ± SD percentage changes of 9.9% ± 9.2, 5% ± 10.3, 6.3% ± 12.6 and -225 
4.8% ± 12.3 for the  neutral, 5° rearfoot,  10° rearfoot and combined 5° forefoot/ 10° rearfoot wedging 226 
conditions respectively. No significant differences were found between mKOA and the healthy group in 227 
relation to 2KAM.    228 
1KFM 229 
For 1KFM, no significant main effects or any interaction effects were found. Although no statistically 230 
significant findings were evident (p=0.109) between the groups the mKOA group demonstrated a mean 231 
(±SD) 1KFM increase of 11.4% ± 26.6 compared to the healthy group, 4.3% ± 26.6. 232 
KAM Impulse 233 
Significant main effects were found for orthotic length in KAM Impulse (p=0.022). Irrespective of the 234 
group, the FO length provided different responses in terms of the KAM Impulse compared to the shod 235 
condition. This corresponded to a mean ± SD KAMI percentage change of 2.1% ± 16.8 for three-quarter 236 
length FOs and 0.4% ± 16.1 for full length FOs. 237 
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Significant interaction effects were found between orthotic length and group (p=0.036). For the mKOA 238 
group this corresponded to a mean ± SD KAMI percentage change of  -0.5% ± 16.3 and -0.7% ± 16.1 for 239 
the ¾ length and full length FOs respectively compared to the healthy group who demonstrated an 240 
increase in KAMI of 4.6% ± 16.3 and 1.5% ± 16.1 for the ¾ length and full length FOs respectively.   241 
Significant main effects were found for wedging for KAM Impulse (p<0.0001). Irrespective of group the 242 
effect of wedging condition corresponded to mean ± SD percentage changes of 5.9% ± , 0.9% ± 11, 0.9% 243 
± 9 and -2.6% ± 10 for the neutral, 5° rearfoot; 10° rearfoot and combined 5° forefoot/ 10° rearfoot posted  244 
conditions respectively. 245 
Although borderline the interaction between wedging and orthotic length was not significant (p=0.055). 246 
For the ¾ length FOs alterations to wedging corresponded to mean ± SD percentage changes of  3 % ±13, 247 
1% ± 9  and 0% ± 9  for the  5° rearfoot; 10° rearfoot and combined 5° forefoot/ 10° rearfoot wedging 248 
conditions respectively. The full length FO demonstrated a slightly different pattern corresponding to 249 
mean ± SD percentage changes of  2% ± 9,  10% ± 2 and -6% ± 10 for the  5° rearfoot; 10° rearfoot and 250 
combined 5° forefoot/ 10° rearfoot wedging conditions respectively. 251 
Individual Response 252 
The variable magnitude of response to orthotic changes across the biomechanical outcome measures is 253 
evident when the high standard deviations and confidence intervals are considered. The variability in 254 
biomechanical response was present in both groups. 255 
INSERT FIGURE 2 256 
INSERT FIGURE 3 257 
INSERT FIGURE 4 258 
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INSERT FIGURE 5   259 
Negative and positive responses to FOs were assessed in relation whether the percentage 260 
increase/decrease was greater/less than the reported standard error of the mean (SEM) for each variable. 261 
For 1KAM, 22/80 (27.5%) of the assessments, incorporating the various wedging conditions for the 262 
mKOA group, resulted in a negative biomechanical response over the SEM. The healthy group had an 263 
incidence of 22/80 (27.5%) negative responses. A positive 1KAM response above SEM was found in 264 
44/80 (55%) for both mKOA and healthy groups. For the 2KAM, 41/80 (51.3%) of assessments for the 265 
mKOA group caused an inverse biomechanical response over the SEM. This compared to 58/80 (72.3%) 266 
negative responses for healthy group. A positive 2KAM response above SEM was found in 25/80 267 
(31.3%) and 15/80 (18.8%) for mKOA and healthy groups respectively. For KAMI, 29/80 (36.3%) of the 268 
assessments for the mKOA group demonstrated an inverse biomechanical effect over the SEM. This 269 
compared to 42/80 (52.3%) for the healthy group.  In relation to a positive KAMI response, a reduction 270 
below the SEM was found in 34/80 (42.5%) and 25/80 (31.3%) for mKOA and healthy groups 271 
respectively. For 1KFM, overall 50/80 (62.5%) of the assessments demonstrated an increase in 1KFM in 272 
response for the mKOA group over the SEM. The healthy group demonstrated increased 1KFM in 43/80 273 
(53.8%). Whereas a reduction in 1KFM was reported in 13/80 (16.3%) and 20/80 (25%) for mKOA and 274 
healthy groups respectively 275 




The aim of this study was to investigate alterations in knee joint kinetics as a result of modifications in 278 
design features of personalised FOs. Our findings suggest that when two key design features are altered 279 
there is a significant heterogeneous mechanical response observed at the knee joint in both the OA and 280 
healthy groups during walking. These results enhance our knowledge and understanding as to the 281 
potential benefits of personalising FO interventions in order to provide a more positive immediate 282 
biomechanical effect even when a heterogeneous biomechanical response exists between conditions for 283 
individuals.    284 
At the group level, the full length FOs caused a significant reduction in 1KAM compared to the ¾ length 285 
FOs indicating a better response to full length FOs by both study groups. These findings are similar to 286 
those previously reported that wedging applied to the entire lateral border is more effective at reducing 287 
1KAM than just at the heel (15).  288 
Although significant effects of wedging were found for 2KAM, the majority of conditions resulted in 289 
elevated values, indicative of greater medial compartment loading. Overall the reduction in 1KAM did 290 
not correspond to a reduction in 2KAM for most conditions.  However there was a reduction in 2KAM 291 
for the ¾ length and the full length FOs which incorporated 5° forefoot/ 10° rearfoot wedging. For these 292 
conditions mean 2KAM reduced by 0.5% and 4.7% respectively relative to shod in the mKOA and 293 
healthy group respectively. These reductions in 2KAM are similar to previously reported results(15,28). 294 
During the majority of the 2
nd
 period of stance the forefoot is the only component in contact with the 295 
ground. Biomechanically, it is hypothesised that wedging the entire forefoot section will further increase 296 
the rearfoot eversion moment, through an increase in its lever arm length across a longer period of the 297 
stance phase. Significant correlations have been reported between increased rearfoot eversion moments 298 
and reduced KAM moments (29).  As such, increasing the overall period at which the FO is ‘ 299 
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biomechanically effective’ for therefore makes sense and has been reported to be a key design feature to 300 
reduce KAM variables(15).   301 
No significant main or interaction effects were found for 1KFM however it was evident that the lateral 302 
wedged orthotics provided a concomitant elevation of 1KFM across all FO conditions compared to the 303 
shod. The fact that no significant effects were found between FO conditions suggests that these increases 304 
may be attributable to the orthotic design itself. Walter and colleagues (6) suggested that a corresponding 305 
increase in KFM may attenuate any load reducing benefit of KAM reductions. In this study, our FOs 306 
caused a general elevation in 1KFM of 11.4% in the mKOA group, compared to 4.3% the healthy group 307 
(overall in ~77.5% of all participant responses) therefore it remains unclear as to whether a reduction in 308 
medial contact force would have occurred even with the reported reductions in 1KAM and KAMI 309 
variables. 310 
KAM impulse has been suggested as a more suitable measure to infer the loading of the medial 311 
compartment (30,31) as it takes into consideration both the amplitude of the moment and the total period 312 
of stance. For the mKOA group, KAMI was reduced by all FOs which incorporated lateral wedging. The 313 
full length FO which incorporated 5° forefoot/ 10° rearfoot wedging was found to be the most 314 
biomechanically effective FO. For this condition mean KAMI reduced by 4.9% relative to shod. Given 315 
the slightly longer walking time, it could be argued that the elevated 2KAM values reported could have 316 
translated into the KAMI however rearfoot wedged conditions, which reported increased 2KAM, 317 
demonstrated reductions in KAMI indicating that overall loading still reduced.  318 
The reductions in KAMI in response to lateral wedged FOs are in line with those previously reported in 319 
the literature (32,33). These findings reinforce the suggestion that FOs incorporating increased wedging 320 
across the full length of the lateral side will result in a greater reduction in cumulative load on the knee 321 
joint throughout the stance phase. However, these findings were found at the group level which 322 
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demonstrated a high level of variability. It is important to note that other aspects such as individual 323 
response to pain and tolerance to FO condition have to be taken into consideration when the severity of 324 
lateral wedging is targeted.     325 
In the present study, the variability between subjects in the knee joint loading characteristics of 1KAM, 326 
2KAM and KAMI in response to the FO conditions appears greater to that reported in previous research. 327 
Hinman et al  (32) reported a negative response in 23% of participants with a 5° lateral wedge.  In the 328 
mKOA group alone, across the variables linked to medial compartment loading a negative response was 329 
evident and to a greater extent when FO conditions were grouped together, corresponding to an incidence 330 
of 27.5%, 51.3% and 36.3% negative responses over the SEM for 1KAM, 2KAM and KAMI 331 
respectively. Furthermore , for the 5° lateral forefoot/10° lateral rearfoot wedged FO, considered the most 332 
biomechanically aggressive for reducing medial tibiofemoral compartment loading, participants in both 333 
the mKOA group (2/10) and healthy group (3/10) experienced an increase in 1KAM compared to shod 334 
that was above the conditions SEM. One possible explanation to this variability is that the immediate 335 
assessment of the multiple variations in FO design may have exaggerated these negative effects compared 336 
to other studies which have tended to examine only one FO variation.   337 
The capabilities of AM and FO design methods and their potential application in the orthotic sector have 338 
received increased awareness in recent years. The FO design and manufacturing methods adopted in this 339 
study offer a fast and effective alternative to the traditional orthotic manufacturing methods used in 340 
standard care. For our study, the average time between participant’s fitting sessions to final assessment 341 
was approximately 25 days. Manufacturing time of the 8 remaining insoles only took approximately 56-342 
96 hours print time (2 per day, approximately 4-5 days).  Furthermore, the period between initial scan and 343 
printing of the neutral FOs for the acclimatisation session was as short as 2 days, but was dependent on 344 
total manufacturing volume. Traditional methods including plaster casting on the other hand often involve 345 
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more cumbersome processes which require additional time, particularly during the manufacturing stage 346 
(34).  Future difficulties lie in the practical feasibility of integrating 3D design and manufacturing 347 
technologies into the clinical environment in a way which will optimise patient care, drive down overhead 348 
costs for health organisations and reduce the turnaround period between initial assessment and FO issue. 349 
Furthermore the feasibility of a truly personalised device for each individual using this approach still 350 
requires further assessment. The creation of a more streamlined approach to the process is required in 351 
order to effectively tailor the personalised intervention to the point that it can be confidently predicted 352 
that the intervention will provide a beneficial effect.    353 
Limitations & Conclusion 354 
There are a number of limitations which warrant further discussion. Firstly, participants were instructed to 355 
wear their own current trainer rather than a standardised shoe during testing. This may have contributed to 356 
the variability in biomechanical response, based on the differences in mechanical characteristics of the 357 
footwear, which could influence individual gait patterns. However, this approach was taken to reflect 358 
what participants would wear on a daily basis and was assumed not to disrupt their normal biomechanical 359 
gait pattern based on their routine use. Furthermore, as results are expressed relative to a shod test 360 
condition, this confounding factor is theoretically minimised in the results. We believe the methods 361 
applied in this study provide valid results whilst maintaining a pragmatic approach to an intervention 362 
study.  363 
The cross sectional nature of the study focused on the immediate biomechanical response, with testing of 364 
each FO performed in a random order with little acclimatization period. It is unclear whether each of the 365 
conditions evaluated would have had a different effect if they were worn over an extended period of time. 366 
Turpin and colleagues (35) reported that an extended period of wear would allow suitable acclimatization 367 
to an FO design to occur. However, the immediate biomechanical effect can provide a valuable indicator 368 
18 
 
for longer term clinical outcomes. Hinman et al., (36) demonstrated a significant correlation between 369 
immediate 1
st
 peak KAM reductions with lateral wedged FOs and improvements in WOMAC function 370 
score at 3 month follow up, whereby individuals who demonstrated a greater reduction in the adduction 371 
moment reported less physical disability 372 
The OA population is known to be heterogeneous in nature. These findings of variability in response to 373 
orthotic intervention in people with medial compartment knee OA further support the requirement to 374 
develop a better understanding of responders/non-responders, perhaps based on other biomechanical and 375 
physical characteristics such as altered ankle joint motions (13). 376 
To our knowledge, this study is the first to examine the immediate biomechanical response to multiple 377 
designs of personalised FOs in an mKOA group. These findings suggest that a blanket approach to 378 
orthotic prescription may not be an effective treatment plan irrespective of the perceived benefit at the 379 
group level. This may go some way to explain the negative findings from recent RCTs of this type of 380 
intervention and is a crucial consideration for the KOA population where orthotic prescription is routine 381 
practice. In theory under these methods there could be individuals with knee OA who are being 382 
prescribed FOs which cause increased KAMs possibly exacerbating their OA progression. A greater 383 
understanding is required as to which individuals respond to an orthotic intervention i.e. responder 384 
characteristics, as well as improving the ability to optimise the biomechanical response for each of these 385 
individuals. Difficulties lie in how we identify these “responsive” individuals early so that interventions 386 
can be implemented for long term benefit. Chapman and colleagues (13) reported that the biomechanics 387 
of the ankle/ subtalar joint complex plays an central role in KAM reduction and could perhaps predict 388 
those who are more likely to have a positive response. Furthermore Paterson and colleagues (37) recently 389 
reported a strong relationship between foot and knee pain in people with KOA, resulting in adverse 390 
effects on health outcomes and functionality. Future research requires the integration of in depth 391 
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biomechanical analyses as well as additional clinical and risk factor assessments to identify and perhaps 392 
predict FO responders. Increased involvement of the individual into this process may also be an important 393 
consideration. 394 
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Table 1 Participant Demographics 522 
 mKOA Group (n=10) Healthy Group (n=10) 
Subject characteristics Mean (SD) Mean (SD) 
Gender (F:M) 7:3 7:3 
Age (years) 63.3(8.0) ǂ 55.3 ( 4.0) ǂ 
BMI (kg/m
2
) 27.1 (2.8) ǂ 23.6 (2.3) ǂ  
Foot Posture Index, 
TL/NTL* 2.6 (2.7) 2.2 (2.7) 2.4 (1.6) 2.7 (1.7) 
Predicted Radiographic 
Alignment, TL/NTL* 1.36 (2.2) 2.3 (3.1) 1.4 (1.9) 0.7 (1.9) 
Walking Speed (ms
-1
) 4.7 (0.6) 4.2 (0.9) 
*Test Leg (TL) and Non Test Leg (NTL) 
ǂ Significant differences between groups (p ≤0.05) 
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Table 2 Percentage changes in biomechanical variables relative to the shod test condition (control). 523 
524 
 
3/4 length, 0° ‘neutral’ 3/4 length, 5° RF lateral wedging ¾ length, 10° RF lateral wedging ¾ length, 5° FF / 10° RF lateral wedging 
 
mKOA Control mKOA Control mKOA Control mKOA Control 
Parameter Mean (SD) 95% CI Mean (SD) 95% CI Mean (SD) 95% CI Mean (SD) 95% CI Mean (SD) 95% CI mean ±SD 95% CI Mean (SD) 95% CI Mean (SD) 95% CI 
1KAM 0.1 (8.8) -5.8,5.9 3.6 (8.9) -2.2, 9.5 -1.7 (8.1) -6.4, 3 -1.8 (5.8) -6.5, 2.9 -4 (8.1) -8.7, 0.7 -1.8 (5.7) -6.4, 2.9 -2.6 (6.4) -6.4, 1.3 -0.8 (5.2) -4.6, 3.1 
2KAM 6.9 (10.3) 2, 13.6 11.3 (9.9) 4.6, 18 1.5 (10.1) -4.8, 7.8 11.7 (8.8 5.4, 18 3.7 (11.1) -3.4, 10.7 8.2 (10.1) 1.2, 15.3 -0.5 (5.1) -7, 6 9.4 (12.8) 2.9, 15.9 
1KFM 7.9 (9) 8, 14.9 4.5 (12) -2.5, 11.6 10.9 (21.6) 2, 21.6 1.7 (7.5) -9, 12.4 17.3 (12.4) 9.7, 24.9 5.2 (10.5) -2.4, 12.9 12.8 (15.5) 3.4, 22.3 6.2 (12.8) -3.2, 15.7 
KAMI 4.2 (9.4) -1.7, 10..2 6.8 (8.5) 0.8, 12.7 -2 (10.9) -8.9, 5 4.2 (9.9) -2.7, 11.2 -1.4 (7.9) -7.2, 4.3 4 (9.4) -1.8, 9.7 -2.9 (5.8) -8.3, 2.5 3.6 (9.9) -1.8, 9 
     
 Full length, 0° ‘neutral’ Full length , 5° RF lateral wedging Full length 10° RF lateral wedging Full length , 5° FF / 10° RF lateral wedging 
 mKOA Control mKOA Control mKOA Control mKOA Control 
Parameter Mean (SD) 95% CI Mean (SD) 95% CI Mean (SD) 95% CI Mean (SD) 95% CI Mean (SD) 95% CI mean (SD) 95% CI Mean (SD) 95% CI Mean (SD) 95% CI 
1KAM -0.4 (5.9) -5.8, 5 4.5 (9.8) -0.8, 9.9 -3.6 (10) -9.2, 2.1 -2 (6.7) -7.6, 3.7 -6.8 (6.3) -10.8, 5 -3.4 (5.6) -7.4, 0.6 -5.4 (8.2) -10.5, -2.3 -5.4 (7.2) -10.6, -0.3 
2KAM 8.6 (7.1) 2.6, 14.7 11.1 (10.8) 5, 17.2 3.2 (10.3) -3.7, 10 6.8 (10.3) 0, 13.6 3.6 (11.4) -4.7, 12 8.9 (13.7) 0.5, 17.3 -4.7 (10.2) -12.9, 3.5 -4.8 (14.1) -13, 3.4 
1KFM 10.1 (11) 2.8, 17.4 1.5 (10.9) -5.8, 8.8 12.9 (19.7) 1.2, 24.7 5.5 (15.4) -6.3, 17.2 8.6 (15.2) -0.1, 17.2 6.3 (10.3) -2.3, 14.9 10.7 (20.6) 0.1, 21.4 3.1 (9.4) -7.5, 13.8 
KAMI 5.3 (7.5) -0.5, 11.2 7.3 (9.9) 1.5, 13.2 -1.2 (8.7) -7.1, 4.8 2.3 (9.2) -3.6, 8.3 -2 (7.5) -8.4, 1.5 2.4 (11.4) -4, 8.8 -4.9 (7.6) -11.4, 1.5 -4 (11.5) -12.5, 0.4 
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Table 3 Results of tests of within-subject effects from a two way mixed effects ANOVA (Significant values 525 
are highlighted in bold) 526 
Parameter Effect F p-value 
1st Peak Knee Adduction Moment Length 4.986 0.038 
 
Length x Group 0.161 0.693 
 
Wedging 11.564 <0.0001 
 
Wedging x Group 1.094 0.360 
 
Length x Wedging 1.391 0.255 
 
Length x Wedging x Group 0.318 0.812 
2nd Peak Knee Adduction Moment Length 6.820 .018 
 
Length x Group 5.693 .028 
 
Wedging 14.865 <0.0001 
 
Wedging x Group 0.467 0.706 
 
Length x Wedging 5.466 0.002 
 
Length x Wedging x Group 1.440 0.241 
1st Peak Knee Flexion Moment Length 0.571 0.460 
 
Length x Group 0.261 .616 
 
Wedging 0.800 .499 
 
Wedging x Group 0.097 0.961 
 
Length x Wedging 0.519 0.671 
 
Length x Wedging x Group 0.601 0.617 
Knee Adduction Moment Impulse Length 6.280 0.022 
 
Length x Group 5.114 0.036 
 
Wedging 19.709 <0.0001 
 
Wedging x Group 0.764 0.519 
 
Length x Wedging 3.237 0.029 
 
Length x Wedging x Group 1.008 0.396 
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Figure Legends 527 
Figure 1. Picture of the 3D printing system used in the FDM process (3d Touch; Bits from 528 
Bytes, Clevedon, UK)   529 
Figure 2.  Group and individual changes in the first peak knee adduction moment (1KAM) 530 
for each FO condition, reported as the percentage change relative to shod condition. 531 
Figure 3. Group and individual changes in the second peak knee adduction moment (2KAM) 532 
for each FO condition, reported as the percentage change relative to shod condition. 533 
Figure 4.  Group and individual changes in the first peak knee flexion moment (1KFM) for 534 
each FO condition, reported as the percentage change relative to shod condition. 535 
Figure 5.  Group and individual changes in the knee adduction moment impulse (KAMI) for 536 
each FO condition, reported as the percentage change relative to shod condition. 537 
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